Dolutegravir 50 mg tablet

DRUG2 trials

Sponsors

ViiV Healthcare

Conditions

Infection, Human Immunodeficiency VirusInfections, Human Immunodeficiency Virus and Herpesviridae

Phase 1

Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

CompletedNCT01382238

ViiV HealthcareInfections, Human Immunodeficiency Virus and Herpesviridae

Start: 2011-06-30End: 2011-08-31Updated: 2011-09-19

Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations

CompletedNCT02738931

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2016-05-31End: 2016-06-30Updated: 2017-01-18